Hedgehog pathway inhibitor therapy in basal-cell nevus syndrome

被引：0

作者：

Migden, Michael ^{[1
,2
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA

来源：

LANCET ONCOLOGY | 2016年 / 17卷 / 12期

关键词：

CARCINOMA; VISMODEGIB;

D O I：

10.1016/S1470-2045(16)30574-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1631 / 1632

页数：3

共 10 条

[1] The Use of Vismodegib to Shrink Keratocystic Odontogenic Tumors in Patients With Basal Cell Nevus Syndrome [J].

Ally, Mina S. ;

Tang, Jean Y. ;

Joseph, Timmy ;

Thompson, Bobbye ;

Lindgren, Joselyn ;

Raphael, Maria Acosta ;

Ulerio, Grace ;

Chanana, Anita M. ;

Mackay-Wiggan, Julian M. ;

Bickers, David R. ;

Epstein, Ervin H., Jr. .

JAMA DERMATOLOGY, 2014, 150 (05) :542-545

[2] An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma [J].

Ally, Mina Sarah ;

Aasi, Sumaira ;

Wysong, Ashley ;

Teng, Claudia ;

Anderson, Eric ;

Bailey-Healy, Irene ;

Oro, Anthony ;

Kim, Jinah ;

Chang, Anne Lynn ;

Tang, Jean Yuh .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (05) :904-U304

[3] Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma [J].

Atwood, Scott X. ;

Sarin, Kavita Y. ;

Whitson, Ramon J. ;

Li, Jiang R. ;

Kim, Geurim ;

Rezaee, Melika ;

Ally, Mina S. ;

Kim, Jinah ;

Yao, Catherine ;

Chang, Anne Lynn S. ;

Oro, Anthony E. ;

Tang, Jean Y. .

CANCER CELL, 2015, 27 (03) :342-353

[4] The hedgehog pathway and basal cell carcinomas [J].

Bale, AE ;

Yu, KP .

HUMAN MOLECULAR GENETICS, 2001, 10 (07) :757-762

[5] Initial Assessment of Tumor Regrowth After Vismodegib in Advanced Basal Cell Carcinoma [J].

Chang, Anne Lynn S. ;

Oro, Anthony E. .

ARCHIVES OF DERMATOLOGY, 2012, 148 (11) :1324-1325

[6] NEVOID BASAL-CELL CARCINOMA SYNDROME [J].

GORLIN, RJ .

MEDICINE, 1987, 66 (02) :98-113

[7]

Rogers G, 2016, P AM SOC CLIN ONCO S, V34

[8]

Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713

[9]

Tang JY, 2012, NEW ENGL J MED, V366, P2180, DOI 10.1056/NEJMoa1113538

[10]

Tang JY, 2016, LANCET ONCOL

← 1 →